Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor
申请人:——
公开号:US20040157865A1
公开(公告)日:2004-08-12
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to naphthol, quinoline and isoquinoline-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
本发明涉及辣椒素受体VR1配体。更具体地说,本发明涉及萘酚,喹啉和异喹啉衍生的脲类化合物,它们是VR1的有效拮抗剂或激动剂,对哺乳动物的炎症和其他疼痛症状的治疗和预防有用。